Abstract
Based on our pharmacophore model of the aryl diketoacids (ADKs), we designed and prepared a series of novel ADK analogues, which showed potent inhibitory activities against the NS5B polymerase in the submicromolar range. Pharmacophore-guided docking study revealed that the antiviral activities of the ADKs are highly dependent upon the aryl linker as well as the size and position of the aromatic substituent. It is of another importance that, unlike previously reported ADKs, three ADK analogues synthesized in this study effectively blocked Hepatitis C Virus (HCV) replication in the replicon systems.
| Original language | English |
|---|---|
| Pages (from-to) | 4661-4665 |
| Number of pages | 5 |
| Journal | Bioorganic and Medicinal Chemistry Letters |
| Volume | 18 |
| Issue number | 16 |
| DOIs | |
| State | Published - 15 Aug 2008 |
| Externally published | Yes |
Keywords
- Aromatic substituent
- Aryl diketoacid (ADK)
- Aryl linker
- Hepatitis C virus (HCV)
- Pharmacophore-guided docking